Australia markets open in 8 hours 52 minutes

Sesen Bio, Inc. (SESN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.9129-0.0971 (-9.61%)
At close: 04:00PM EST
0.9231 +0.01 (+1.12%)
Pre-market: 09:07AM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.0100
Open1.0100
Bid0.9300 x 1400
Ask0.9702 x 1800
Day's range0.9100 - 1.0120
52-week range0.7000 - 6.0400
Volume4,956,568
Avg. volume15,502,179
Market cap182.091M
Beta (5Y monthly)0.64
PE ratio (TTM)N/A
EPS (TTM)-0.1470
Earnings date08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.25
  • Business Wire

    Sesen Bio Strengthens Medical Team

    CAMBRIDGE, Mass., November 29, 2021--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the strengthening of its medical team with the hiring of Dominika Kowalski as Senior Director of Global Drug Safety. Ms. Kowalski’s hiring demonstrates Sesen Bio’s strong commitment to and continued focus on the development of Vicineum™ for the treatment of BCG-unresponsive non-muscle invasive bladd

  • Business Wire

    Sesen Bio Director Jane Pritchett Henderson Transitions to CEO Advisor Role

    CAMBRIDGE, Mass., November 23, 2021--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Jane Pritchett Henderson, previously a member of Sesen Bio’s Board of Directors and the Chair of the Board’s Audit Committee, has transitioned off the Board of Directors to a CEO Advisor role, effective November 22, 2021. Ms. Henderson departed the Board in order to concentrate on other respons

  • Simply Wall St.

    Sesen Bio (NASDAQ:SESN) investors are sitting on a loss of 52% if they invested five years ago

    Sesen Bio, Inc. ( NASDAQ:SESN ) shareholders should be happy to see the share price up 25% in the last month. But don't...